Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
Clinical trial NCT06912529 · TERMINATED
Trial details
- NCT number
- NCT06912529
- Sponsor
- Universität Münster
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2025-07-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.